Biologics Market Scenario | New Growth Opportunities | Top Key Players - Merck & Co., Inc., AbbVie Inc

The Business Research Company’s latest "Global Biologics Opportunities And Strategies Market Report – Forecast To 2025" is the most comprehensive report available in market that will help gain a truly global perspective with data and statistics from over 60 geographies analyzed with more than 2500 market segments. The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by region and by country. It also compares the market’s historic and forecast growth and highlights important trends and strategies that can be adopted to beat the competition in the industry

Place a DIRECT PURCHASE ORDER of the report @
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=792

The global biologics market reached a value of nearly $253,414.8 million in 2020, having increased at a compound annual growth rate (CAGR) of 8.7% since 2015. The market is expected to grow from $253,414.8 million in 2020 to $420,551.5 million in 2025 at a rate of 10.7%. The market is then expected to grow at a CAGR of 9.6% from 2025 and reach $664,744.2 million in 2030.

The biologics market consists of sales of biologics and related services by entities (organizations, sole traders and partnerships) that produce biologics or biosimilars to treat and prevent various microbial diseases and cancers. The biologics market comprises companies manufacturing biological products that are derived from genetically modified proteins and human genes. Biologics products include a wide range of recombinant therapeutic proteins, gene therapy tissues, somatic cells, vaccines, and allergenics.

Biologics Market Segmentation:
1. By Type: Therapeutic Proteins, Monoclonal Antibodies (MAbS), Vaccines
2. By Route Of Administration: Oral, Others (IV and IP)
3. By Drug Classification: Branded Drugs, Generic Drugs
4. By Mode Of Purchase: Prescription Drugs, Over-The-Counter (OTC) Drugs
5. By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Some of the key players involved in the biologics market are Merck & Co., Inc., AbbVie Inc., F. Hoffmann-La Roche AG, Johnson & Johnson, Pfizer Inc.

The regions covered in the global biologics market are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Complete Report @
https://www.thebusinessresearchcompany.com/report/biologics-market

A Few Points From The Table Of Content
1. Biologics Market Executive Summary
2. Table Of Contents
3. List Of Figures
4. List Of Tables
5. Report Structure
6. Introduction
……
25. Key Mergers And Acquisitions In The Biologics Market
26. Market Background: Pharmaceuticals Market
27. Biologics Market Opportunities And Strategies
28. Biologics Market, Conclusions And Recommendations
29. Appendix

Contact us:

The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
And check out our Blog: http://blog.tbrc.info/

Interested to know more about The Business Research Company?

The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that excels in company, market, and consumer research. Located globally, it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology.

The World’s Most Comprehensive Database

The Business Research Company’s flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.

This release was published on openPR.